# Biocryst Pharmaceuticals Inc: Form 8-K, filed Mar 11, 2025

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2025-03-11
- Accepted by EDGAR: Mar 11, 2025, 06:26 ET
- Period: 2025-03-10
- Accession: 0001171843-25-001383
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184325001383/f8k_031125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184325001383/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184325001383/f8k_031125.htm

Filed Mar 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-001383. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.